Changshan Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Changshan Sun has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Tiemin Sun
Shenyang Pharmaceut Univ, Key Lab Struct Based Drug Design & Discovery, Minist Educ, Shenyang 110016, Peoples R China
4 shared publications Chengjun Wu
Key Laboratory of Structure-Based Drug Design and Discovery, Shenyang Pharmaceutical University, Ministry of Education, Shenyang 110016, PR China
2 shared publicationsLinwei Li
Key Laboratory of Structure-Based Drug Design and Discovery, Shenyang Pharmaceutical University, Ministry of Education, Shenyang 110016, PR China
2 shared publicationsZhen Li
Key Laboratory of Structure-Based Drug Design and Discovery, Shenyang Pharmaceutical University, Ministry of Education, Shenyang 110016, PR China
2 shared publicationsBiyun Tu
Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China
1 shared publicationCaishun Chen
Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning Province, 110016, PR China
1 shared publication
Latest Publications
- 1 June 2020
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 190, 110941
Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor
- 1 June 2020
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 190, 110941
Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor
- 1 June 2019
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 108 (6) , 2143-2152
A Delivery System for Oral Administration of Proteins/Peptides Through Bile Acid Transport Channels
- 1 June 2019
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 108 (6) , 2143-2152
A Delivery System for Oral Administration of Proteins/Peptides Through Bile Acid Transport Channels
- 30 May 2019
- Published by Elsevier in Journal of Molecular Liquids
- Vol. 288, 111055
Theoretical studies on racemization of levetiracetam: Structural movements, character of hydroxide ion and guidelines for efficient control
- 30 May 2019
- Published by Elsevier in Journal of Molecular Liquids
- Vol. 288, 111055
Theoretical studies on racemization of levetiracetam: Structural movements, character of hydroxide ion and guidelines for efficient control
- 27 February 2019
- Published by Wiley in ChemCatChem
- Vol. 11 (7) , 1943-1948
An Efficient, Scalable and Eco‐friendly Synthesis of 4,5‐substituted Pyrrole‐3‐Carbonitriles by Intramolecular Annulation on Pd/C and HZSM‐5
An efficient and eco‐friendly protocol for the synthesis of diverse 4,5‐substituted 1H‐pyrrole‐3‐carbonitriles has been developed using commercially available HZSM‐5 and Pd/C as recyclable heterogeneous catalysts with more excellent yields (up to 98 %) than traditional liquids acids, and successfully applied in the practical synthesis of vonoprazan. The conspicuous features of this protocol are higher product yield, easy work‐up, eco‐friendly and reusability of catalysts.
- 27 February 2019
- Published by Wiley in ChemCatChem
- Vol. 11 (7) , 1943-1948
An Efficient, Scalable and Eco‐friendly Synthesis of 4,5‐substituted Pyrrole‐3‐Carbonitriles by Intramolecular Annulation on Pd/C and HZSM‐5
An efficient and eco‐friendly protocol for the synthesis of diverse 4,5‐substituted 1H‐pyrrole‐3‐carbonitriles has been developed using commercially available HZSM‐5 and Pd/C as recyclable heterogeneous catalysts with more excellent yields (up to 98 %) than traditional liquids acids, and successfully applied in the practical synthesis of vonoprazan. The conspicuous features of this protocol are higher product yield, easy work‐up, eco‐friendly and reusability of catalysts.
- Open Access
Synthesis, Crystal Structure, Absolute Configuration and Antitumor Activity of the Enantiomers of 5-Bromo-2-chloro-N-(1-phenylethyl)pyridine-3-sulfonamide
Pyridinesulfonamide is an important fragment which has a wide range of applications in novel drugs. R- and S-isomers of 5-bromo-2-chloro-N-(1-phenylethyl)pyridine-3-sulfonamide have been synthesized, and the stereostructures have been researched. Single crystals of both compounds were obtained for X-ray analysis, and the absolute configurations (ACs) have been further confirmed by electronic circular dichroism (ECD), optical rotation (OR) and quantum chemical calculations. The crystal structures and calculated geometries were extremely similar, which permitted a comparison of the relative reliabilities of ACs obtained by ECD analyses and theoretical simulation. In addition, the effect of stereochemistry on the PI3Kα kinase and anticancer activity were investigated. Compounds 10a and 10b inhibit the activity of PI3Kα kinase with IC50 values of 1.08 and 2.69 μM, respectively. Furthermore, molecular docking was performed to analyze the binding modes of R- and S-isomers.
Open AccessSynthesis, Crystal Structure, Absolute Configuration and Antitumor Activity of the Enantiomers of 5-Bromo-2-chloro-N-(1-phenylethyl)pyridine-3-sulfonamide
Pyridinesulfonamide is an important fragment which has a wide range of applications in novel drugs. R- and S-isomers of 5-bromo-2-chloro-N-(1-phenylethyl)pyridine-3-sulfonamide have been synthesized, and the stereostructures have been researched. Single crystals of both compounds were obtained for X-ray analysis, and the absolute configurations (ACs) have been further confirmed by electronic circular dichroism (ECD), optical rotation (OR) and quantum chemical calculations. The crystal structures and calculated geometries were extremely similar, which permitted a comparison of the relative reliabilities of ACs obtained by ECD analyses and theoretical simulation. In addition, the effect of stereochemistry on the PI3Kα kinase and anticancer activity were investigated. Compounds 10a and 10b inhibit the activity of PI3Kα kinase with IC50 values of 1.08 and 2.69 μM, respectively. Furthermore, molecular docking was performed to analyze the binding modes of R- and S-isomers.
- 18 February 2012
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 39 (1) , 62-66
In vitroandin vivoevaluation of a novel diltiazem hydrochloride polydispersity sustained-release system
Objective: To microencapsulate diltiazem hydrochloride (DH) drug-resin to obtain obvious sustained release effect in vitro and in vivo. Methods: The drug-resinates were made by bath method. The drug-resinates microcapsules were prepared with the ratio of the concentration of coating materials being 1% and the ratio of drug-resin complexes to coating materials being 10:1 by emulsion-solvent diffusion method. The pharmacokinetic of the sustained-release DH microspheres in beagle dogs was carried out. Results: The microencapsulated ion-exchange resin beads containing DH showed sustained-release characteristics for 12 h and exhibited complete release. The pharmacokinetics parameters of DH sustained-release microspheres and reference tablet was AUC0–24 (ng·h·mL−1) 836.3 and 857.3, Cmax (ng·mL−1) 85.4 and 135.2, Tmax (h) 4.7 and 1.2. Conclusion: The mononucleated microencapsulated ion-exchange resin beads showed obvious sustained release character in vitro. The pharmacokinetic of the DH microspheres showed that the test dosage forms were bioequivalent with reference dosage form and had an obviously sustained release effect in vivo.
- 18 February 2012
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 39 (1) , 62-66
In vitroandin vivoevaluation of a novel diltiazem hydrochloride polydispersity sustained-release system
Objective: To microencapsulate diltiazem hydrochloride (DH) drug-resin to obtain obvious sustained release effect in vitro and in vivo. Methods: The drug-resinates were made by bath method. The drug-resinates microcapsules were prepared with the ratio of the concentration of coating materials being 1% and the ratio of drug-resin complexes to coating materials being 10:1 by emulsion-solvent diffusion method. The pharmacokinetic of the sustained-release DH microspheres in beagle dogs was carried out. Results: The microencapsulated ion-exchange resin beads containing DH showed sustained-release characteristics for 12 h and exhibited complete release. The pharmacokinetics parameters of DH sustained-release microspheres and reference tablet was AUC0–24 (ng·h·mL−1) 836.3 and 857.3, Cmax (ng·mL−1) 85.4 and 135.2, Tmax (h) 4.7 and 1.2. Conclusion: The mononucleated microencapsulated ion-exchange resin beads showed obvious sustained release character in vitro. The pharmacokinetic of the DH microspheres showed that the test dosage forms were bioequivalent with reference dosage form and had an obviously sustained release effect in vivo.